Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Waterford Institute Of Technology has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed between 2 distinct examiners and multiple art units. This arrangement means that each pending action is being handled by a different examiner in a different specialized group at the patent office.
BECKHARDT, LYNDSEY MARIE is the busiest examiner for the portfolio, with 1 pending office action. With 2 pending office actions in total, the action assigned to BECKHARDT, LYNDSEY MARIE accounts for a portion of the current portfolio activity. The involvement of 2 distinct art units for the pending actions suggests that the institute's biotechnology research covers multiple distinct technical areas. This decentralized review process allows for specialized examination of each unique research project by different technical experts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18612639 | MICROEMULSION FOR OPHTHALMIC DRUG DELIVERY | BECKHARDT, LYNDSEY MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18612639 | MICROEMULSION FOR OPHTHALMIC DRUG DELIVERY | BECKHARDT, LYNDSEY MARIE | — |
| 17290857 | ARTIFICIAL TEARS | RICCI, CRAIG D | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18612639 | MICROEMULSION FOR OPHTHALMIC DRUG DELIVERY | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 17290857 | ARTIFICIAL TEARS | RICCI, CRAIG D | 1611 | DP | Final Rejection | — | Pending | May 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial